Rifabutin based triple therapy for eradication of H. pylori primary and secondary resistant to tinidazole and clarithromycin (Q44356223)

From Wikidata
Jump to navigation Jump to search
scientific article published in January 2005
edit
Language Label Description Also known as
English
Rifabutin based triple therapy for eradication of H. pylori primary and secondary resistant to tinidazole and clarithromycin
scientific article published in January 2005

    Statements

    Rifabutin based triple therapy for eradication of H. pylori primary and secondary resistant to tinidazole and clarithromycin (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit